Study #2022-0301
Prospective evaluation of a gene expression- based risk classifier for patients with STS treated with pazopanib
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Prospective eval of a gene expression-based risk classifier for pts with STS treated with pazopanib
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Soft Tissue
Study phase:
Not applicable
Physician name:
Vinod Ravi
Department:
Sarcoma Medical Oncology
For general questions about clinical trials:
1-844-936-4810
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.